Actualités réglementaires
30 août 2026•1 min de lecture
FDA Approves ANDA 085702 for Phendimetrazine Tartrate Oral Capsule
Sandoz's oral capsule product PHENDIMETRAZINE TARTRATE (35 mg) under application ANDA085702 has received FDA approval; the product is listed as discontinued.
Actualités réglementaires
30 août 2026•1 min de lecture
FDA Discontinues Alprazolam Extended‑Release Tablets (ANDA077777)
FDA records show Sandoz's alprazolam extended‑release tablets (product numbers 001‑004) are discontinued, with multiple labeling supplement approvals.